2023. Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s247. DOI:https://doi.org/10.25251/skin.7.supp.247.